MDLZ
36
6
KR
50
4
GLW
48
4
GRMN
59
6
MNST
52
6
KEY
27
3
CMG
64
3
CMA
46
3
IPG
42
2
COF
52
5
SYK
57
6
ICE
55
2
PSX
27
2
K
53
5
RHI
50
2
LNC
29
4
HSY
34
3
MCD
57
5
DGX
29
2
MMC
50
4
MDLZ
36
6
KR
50
4
GLW
48
4
GRMN
59
6
MNST
52
6
KEY
27
3
CMG
64
3
CMA
46
3
IPG
42
2
COF
52
5
SYK
57
6
ICE
55
2
PSX
27
2
K
53
5
RHI
50
2
LNC
29
4
HSY
34
3
MCD
57
5
DGX
29
2
MMC
50
4
Financhill
Back

Rhythm Pharmaceuticals 10K Form

Sell
46

RYTM
Rhythm Pharmaceuticals

Last Price:
$55.81
Seasonality Move:
-14.94%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RYTM News And Ratings

See the #1 stock for the next 7 days that we like better than RYTM

RYTM Financial Statistics

Sales & Book Value

Annual Sales: $77.4M
Cash Flow: $14.8M
Price / Cash Flow: 0
Annual Sales: $0.18
Price / Book: 306.05

Profitability

EPS (TTM): -4.33000
Net Income (TTM): $-258.9M
Gross Margin: $68.1M
Return on Equity: -208.96%
Return on Assets: -76.55%

Rhythm Pharmaceuticals Earnings Forecast

Key Rhythm Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 6 years for RYTM is 87.99%.
  • The Selling, General & Administrative Expenses for RYTM have been equal to 151.80% of Gross Profit Margin.
  • The Research & Development expenses have been 174.29% of Revenue.
  • The Interest Expense is -7.52% of Operating Income.
  • The Net Earning history of RYTM is -238.52% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 4 years.

Rhythm Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: RYTM
CUSIP: 76243J
Website: rhythmtx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 3.49
Quick Ratio: 3.25

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

RYTM Technical Analysis vs Fundamental Analysis

Sell
46
Rhythm Pharmaceuticals (RYTM) is a Sell

Is Rhythm Pharmaceuticals a Buy or a Sell?